Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,004 | 1,948 | 206 | 1,347 | 4 |
| Inventories | 253 | 35 | N/A | N/A | N/A |
| TOTAL | $1,312 | $2,403 | $989 | $1,966 | $148 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $1,312 | $2,403 | $989 | $1,966 | $148 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,791 | 6,240 | 5,643 | 5,054 | N/A |
| Accounts payable and accrued liabilities | 1,368 | 1,415 | 2,084 | 1,786 | 310 |
| Accrued Expenses | 1,009 | 267 | N/A | 319 | N/A |
| Other current liabilities | 41 | 3,554 | N/A | N/A | 111 |
| TOTAL | $7,593 | $13,861 | $10,557 | $9,869 | $1,688 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 96 | 10 | 49 | 49 | 0 |
| TOTAL | $96 | $10 | $49 | $49 | $N/A |
| Total Liabilities | $7,689 | $13,870 | $10,606 | $9,918 | $1,688 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,024 | 2,687 | 1,238 | 1,238 | 1,223 |
| Common Shares | 0 | 5 | 5 | 5 | 0 |
| Retained earnings | -27,258 | -22,550 | -20,700 | -18,719 | -2,777 |
| TOTAL | $-6,376 | $-11,467 | $-9,617 | $-7,953 | $-1,540 |
| Total Liabilities And Equity | $1,312 | $2,403 | $989 | $1,966 | $148 |